title: Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers.
authors.affiliation: Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden. jonas.hugosson@vgregion.se
authors.forename: J
authors.initials: J
authors.lastname: Hugosson
authors.forename: H
authors.initials: H
authors.lastname: Lilja
authors.forename: P
authors.initials: P
authors.lastname: Lodding
authors.forename: C G
authors.initials: CG
authors.lastname: Pihl
mesh_terms: D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*